This study reveals increased BCLAF1 expression in hepatocellular carcinoma (HCC) patients, in whom elevated BCLAF1 levels are linked to escalated tumor grades and diminished survival rates. This evidence concerns the gene BCLAF1 and hepatocellular carcinoma.